Citations

Clear

367 citation(s) found for "Benson, Al".

Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis
Aaen, Gregory , Waltz, Michael , Vargas, Wendy , Makhani, Naila , Ness, Jayne , Harris, Yolanda, Casper, T. Charles , Candee, Meghan , Gorman, Mark , Greenberg, Benjamin , Lotze, Timothy , Mar, Soe , Tillema, Jan‐Mendelt , Rodriguez, Moses , Rose, John , Rubin, Jennifer , Schreiner, Teri , Belman, Anita , Krupp, Lauren , Krupp, Lauren , Rodriguez, Moses , Greenberg, Benjamin M , Benson, Leslie, Chitnis, Tanuja , Graves, Jennifer , Rensel, Mary R. , Schreiner, Teri , Waldman, Amy , Weinstock‐Guttman, Bianca , Waubant, Emmanuelle L. , Rubin, Jennifer P

Mayo Clinic

Journal of Child Neurology | December 17, 2018 | Volume: 34 | Issue: 3 | Pages: 148-152

10.1177/0883073818815041 | PMID 30556452 Get It

Children with pediatric-onset multiple sclerosis and pediatric controls were enrolled across 16 pediatric multiple sclerosis centers in the United States and completed questionnaires that addressed time of first unaided walking and acquisition of 2-word phrases. A total of 467 (308 female) cases and 428 (209 female) controls were enrolled. Pediatric multiple sclerosis (n = 467) were not delayed in walking or using 2-word phrases compared to healthy controls (n = 428) (2.2% vs 5.7%, respectively). Children with disease onset before age 11 versus onset at 11 years or after were more likely to need an individualized education plan ( P = .002), reading assistance ( P = .0003), and math assistance ( P = .001). Children with multiple sclerosis onset prior to age 18 are not delayed in meeting the 2 major early developmental milestones but do have a significantly increased use of special services or learning assistance at school. Further research will need to address whether other measures of development (eg, rate of language acquisition or fine motor skills) differ between pediatric multiple sclerosis and controls.
Several household chemical exposures are associated with pediatric‐onset multiple sclerosis
Mar, Soe , Liang, Shannon , Waltz, Michael , Casper, T. Charles , Greenberg, Benjamin , Rodriguez, Moses , Aaen, Gregory , Belman, Anita , Barcellos, Lisa F. , Rose, John , Gorman, Mark , Candee, Meghan , Chitnis, Tanjua, Harris, Yolanda, Kahn, Ilana , Roalsted, Shelly, Hart, Janace, Lotze, Timothy , Moodley, Manikum , Ness, Jayne , Rubin, Jennifer , Schreiner, Teri , Tillema, Jan‐Mendelt , Krupp, Lauren , Krupp, Lauren , Rodriguez, Moses , Greenberg, Benjamin M , Goyal, Manu S. , Weinstock‐Guttman, Bianca , Benson, Leslie , Rensel, Mary R. , Schreiner, Teri , Waldman, Amy , Graves, Jennifer , Waubant, Emmanuelle L. , Rubin, Jennifer P

Mayo Clinic

Annals of Clinical and Translational Neurology | October 10, 2018 | Volume: 5 | Issue: 12 | Pages: 1513-1521

10.1002/acn3.663 | PMID 30564618 Get It

AbstractBackgroundThere is limited information about the potential associations of multiple sclerosis (MS) and commonly used household chemicals.MethodsWe performed a case‐control study of exposures to common household chemicals during childhood in children with MS and healthy pediatric controls. Exposures to household products were collected from a comprehensive questionnaire (http://www.usnpmsc.org/Documents/EnvironmentalAssessment.pdf) completed by parents at the time of enrollment in the study. Cases included children diagnosed with MS or clinically isolated syndrome with at least two silent T2 bright lesions on MRI, recruited within 4 years of disease onset from 16 pediatric MS clinics in the USA. Multivariate analyses using logistic regression were adjusted for possible confounders including age, sex, race, ethnicity, mother's highest level of education, and urban versus rural living.ResultsQuestionnaire responses to household chemicals were available for 312 eligible cases (median age 15.7 years, 63% girls) and 490 healthy controls (median age 15.0, 57% girls). Exposure to rodenticides (odds ratio [OR] 2.10, 95% confidence interval [CI] 1.35–3.26, P ≤ 0.001), weed control agents (OR 1.99, 95% CI 1.36–2.92, P ≤ 0.001) and products for plant/tree disease control (OR 2.72, 95% CI 1.54–4.82, P ≤ 0.001) anytime during childhood were associated with an increased risk for pediatric‐onset MS in adjusted and multiple comparisons analyses.ConclusionsOur findings suggest that exposure to specific household chemicals during early childhood is associated with the risk of developing pediatric‐onset MS. Future studies are needed to elucidate a causal relationship and the exact agents involved.
Urban air quality and associations with pediatric multiple sclerosis
Lavery, Amy M. , Casper, T. Charles , Roalstad, Shelly, Candee, Meghan , Rose, John , Belman, Anita , Aaen, Greg, Tillema, Jan‐Mendelt , Rodriguez, Moses , Ness, Jayne , Harris, Yolanda, Krupp, Lauren , Charvet, Leigh , Gorman, Mark , Moodley, Manikum , Mar, Soe , Schreiner, Teri , Lotze, Tim, Greenberg, Benjamin , Kahn, Ilana , Rubin, Jennifer , Krupp, Lauren , Rodriguez, Moses , Greenberg, Benjamin M , Charvet, Leigh E , Waubant, Emmanuelle L. , Weinstock‐Guttman, Bianca , Aaen, Gregory , Graves, Jennifer , Benson, Leslie , Rensel, Mary R. , Goyal, Manu S. , Chitnis, Tanuja , Schreiner, Teri , Waldman, Amy , Rubin, Jennifer P

Mayo Clinic

Annals of Clinical and Translational Neurology | September 28, 2018 | Volume: 5 | Issue: 10 | Pages: 1146-1153

10.1002/acn3.616 | PMID 30349849 Get It

AbstractBackgroundWe previously identified air quality as a risk factor of interest for pediatric multiple sclerosis. The purpose of this study is to more closely examine the association between the six criteria air pollutants and pediatric MS as well as identify specific areas of toxic release using data from the Toxic Release Inventory.MethodsPediatric MS cases (N = 290) and healthy controls (N = 442) were included as part of an ongoing case–control study. We used the National Emissions Inventory system to estimate particulate exposure by county of residence for each participant. Proximity to Toxic Release Inventory (TRI) sites was also assessed using ArcGIS mapping tools. Risk‐Screening Environmental Indicators (RSEI) classified counties at risk to exposure of environmental toxic releases.ResultsFine particulate matter (PM2.5), carbon monoxide (CO), sulfur dioxide (SO2), and lead air emissions were associated with increased odds for pediatric MS (P < 0.01) for those residing within 20 miles of an MS center. Most study participants (75%) resided within 5 miles of at least one TRI site; however, the mean total pounds of stack air releases was higher for sites near MS cases (81,000 tons) compared to those near healthy controls (35,000 tons, P = 0.002). Average RSEI scores did not differ significantly between cases and controls.ConclusionOut of several air pollutants examined, we show that fine particulate matter and three other criteria pollutants (SO2, CO, and lead) were statistically associated with higher odds for pediatric MS.
Heterogeneity in association of remote herpesvirus infections and pediatric MS
Rutatangwa, Alice , Waltz, Michael , Moodley, Manikum , Casper, T. Charles , Belman, Anita , Greenberg, Benjamin , Harris, Yolanda, Kahn, Ilana , Lotze, Timothy , Mar, Soe , Schreiner, Teri , Aaen, Gregory , Hart, Janace, Ness, Jayne , Rubin, Jennifer , Tillema, Jan‐Mendelt , Gorman, Mark , Rodriguez, Moses , Rose, John , Candee, Meghan , Shao, Xiaorong, Barcellos, Lisa F. , Rodriguez, Moses , Greenberg, Benjamin M , Nourbakhsh, Bardia , Rensel, Mary R. , Graves, Jennifer , Waldman, Amy , Goyal, Manu S. , Schreiner, Teri , Krupp, Lauren , Benson, Leslie, Chitnis, Tanuja , Weinstock‐Guttman, Bianca , James, Judith A. , Waubant, Emmanuelle L. , Edwards, Alice Rutatangwa , Rubin, Jennifer P

Mayo Clinic

Annals of Clinical and Translational Neurology | September 17, 2018 | Volume: 5 | Issue: 10 | Pages: 1222-1228

10.1002/acn3.636 | PMID 30349857 Get It

AbstractObjectiveWhile prior Epstein–Barr virus (EBV) infection has been consistently associated with subsequent risk of developing multiple sclerosis (MS), the association with other common herpesviruses has been more controversial. Our objectives were to determine whether remote infection with EBV and other common herpesviruses affect the susceptibility to pediatric MS and if there are interactions between genetic and demographic factors and viral infections.MethodsCases with pediatric‐onset MS or clinically isolated syndrome within 4 years of disease onset, and controls were recruited from 16 American pediatric MS centers. Logistic regression models adjusted for potential confounders assessed the association between case status and serological evidence for past infection with EBV, cytomegalovirus (CMV), Herpes Simplex viruses‐1 (HSV‐1) and ‐2. We determined the heterogeneity of the effect of viral infection on the risk of having MS according to race, ethnicity and HLA‐DRB1:1501 status.ResultsA total of 356 pediatric cases and 493 controls were recruited. In multivariable models, EBV‐viral capsid antigen (VCA) seropositivity was associated with increased odds of having MS by 7.4 times (95% CI: 4.5–12.0, P < 0.001). Seropositivity for HSV‐1 was also associated with increased odds of having MS (OR 1.54, 95% CI: 1.06–2.25, P = 0.025) but this increase was seen only in Whites (OR = 2.18, 95% CI 1.35–3.52, P < 0.001) and those negative for HLA‐DRB1*1501 (OR = 1.89, 95% CI 1.17–3.03, P = 0.009). The effect of remote EBV infection on the risk of pediatric MS depended on race and HLA‐DRB1*15:01 status.InterpretationEBV seropositivity is strongly associated with pediatric MS, as is HSV‐1 seropositivity in subjects negative for HLA‐DRB1*15:01. Our report of interactions between select viral exposures, and age, race and DRB1 status suggests a complex effect of environmental and genetic risk factors on MS development.
Association of immune markers and Immunoscore with survival of stage III colon carcinoma (CC) patients (pts) treated with adjuvant FOLFOX: NCCTG N0147 (Alliance).
Hermitte, Fabienne , Heying, Erica N., Benson, Al B. , Goldberg, Richard M. , Kahlenberg, Morton S., Nair, Suresh , Shields, Anthony F. , Galon, Jerome , Sinicrope, Frank A. , Shi, Qian , Gill, Sharlene , Sargent, Daniel J. , Galon, Jérôme , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 35 | Issue: 15_suppl | Pages: 3579-3579

10.1200/jco.2017.35.15_suppl.3579 Get It

3579 Background: Tumor infiltrating lymphocytes (TIL) indicate a host immune response that may influence survival. Immunoscore was developed using CD3+ and CD8+density and location in primary CC pts with pooled stages, varying treatment and follow-up. We determined if individual immune markers and/or Immunoscore are prognostic in resected stage III CC pts (N=600). Methods: CD3+ and CD8+ T-cell or CD20+ B lymphocyte density in central tumor (CT) and invasive margin (IM) was evaluated by immunostaining and quantified by image analysis. Immunoscore was calculated on a scale of I0 to I4 with high densities of CD3+ and CD8+in both CT and IM scored as I4; low densities scored as I0. Associations with disease-free survival (DFS) were evaluated by multivariable Cox regression adjusting for covariates. Results: Data for CD3+, CD8+ and CD20+ were generated (N=595). Higher density of CD3+ CT, CD3+ IM and CD8+ IM were associated with longer DFS adjusting for covariates (Table). CD3+ IM had the strongest association with DFS, and was stronger in left-sided (HRadj.=0.81, 95% CI, 0.70-0.94, padj.= 0.0049) vs right-sided (HRadj.=0.93, 95% CI, 0.85-1.0 padj.=0.52) tumors (pinteraction=0.039). Higher density of CD3+ IM was associated with older age (p=0.034), T1/2 (p<.0001), N1 (p=0.017), right-sided (p=0.013), high TILs (p=0.0008), and deficient MMR (p=0.0003). Using a prior Immunoscore risk stratification, higher scores were associated with better DFS (HR.=0.62, CI, 0.44-0.87, p=0.006) (Table). Conclusions: Densities of CD3+ and CD8+, especially at IM, are individually prognostic in FOLFOX-treated pts. Association of CD3+IM with prognosis differed by primary CC site. Immunoscore was strongly prognostic, and this result provides validation in a clinical trial cohort. [Table: see text]
Intergroup randomized phase III study of postoperative oxaliplatin, 5-fluorouracil and leucovorin (mFOLFOX6) vs mFOLFOX6 and bevacizumab (Bev) for patients (pts) with stage II/ III rectal cancer receiving pre-operative chemoradiation.
Benson, Al B. , Meropol, Neal J. , Catalano, Paul J. , Chakravarthy, Bapsi, Flynn, Patrick J. , Catalano, Robert B., Giantonio, Bruce J. , Mitchell, Edith P. , Haller, Daniel G. , Leichman, Cynthia G., Petrelli, Nicholas J. , Tepper, Joel E. , Brierley, James D. , Sigurdson, Elin R., Whittington, Richard M., O’Dwyer, Peter J. , Chakravarthy, A. Bapsi , Zhao, Fengmin , Sinicrope, Frank A. , Whittington, Richard M.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3616-3616

10.1200/jco.2016.34.15_suppl.3616 Get It

Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance)
Blarigan, Erin L. Van , Ou, Fang‐Shu , Niedzwiecki, Donna , Zhang, Sui , Fuchs, Charles S. , Ogino, Shuji , Benson, A.B., Hantel, Alexander, Atkins, James N., Giovannucci, Edward L. , Meyerhardt, Jeffrey A. , Saltz, Leonard , Ogino, Shuji , Meyerhardt, Jeffrey A , Ou, Fang-Shu , Niedzwiecki, Donna , Saltz, Leonard B. , Mayer, Robert J. , Venook, Alan P. , Song, Mingyang

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | July 23, 2018 | Volume: 27 | Issue: 10 | Pages: 1227-1230

10.1158/1055-9965.epi-18-0487 | PMID 30038051 Get It

Abstract Background: Higher intake of long-chain ω-3 polyunsaturated fatty acids and nuts, rich plant sources of unsaturated fats, after colon cancer diagnosis are associated with improved survival. It is not known whether the amount or the distribution of other types of fat is associated with survival after colon cancer. Methods: We prospectively examined postdiagnostic total, animal, and vegetable fats, as well as the saturated, monounsaturated, polyunsaturated, and trans fat in relation to disease-free survival among 1,011 patients with stage III colon cancer. Patients were enrolled between 1999 and 2001 at the onset of adjuvant chemotherapy and followed for recurrence or death through 2009. Results: During median follow-up of 7 years, we observed 305 deaths and 81 recurrences (total events: 386). Neither total nor any specific type of dietary fat examined was statistically significantly associated with risk of cancer recurrence or death from any cause (disease-free survival) after stage III colon cancer. Conclusions: The amount and type (animal, vegetable, saturated, monounsaturated, polyunsaturated, and trans) of dietary fat consumed after colon cancer does not appear to be substantially associated with risk of recurrence or survival. Impact: Neither total nor major types (animal, vegetable, saturated, monounsaturated, polyunsaturated, and trans) of dietary fat consumed after colon cancer was associated with cancer recurrence or survival. Cancer Epidemiol Biomarkers Prev; 27(10); 1227–30. ©2018 AACR.
Cardiovascular Disease Screening Practices Among Obstetrics and Gynecology Providers in Minnesota
Witt, Dawn , Benson, Gretchen , Miedema, Michael D. , Boucher, Jackie L., Laughlin-Tommaso, Shannon K., Gamam, Safa, White, Susan , Lindquist, Ruth , Hayes, Sharonne N.

Mayo Clinic

Journal of the Minneapolis Heart Institute Foundation | July 5, 2018 | Volume: 2 | Issue: 1 | Pages: 32-37

10.21925/mplsheartjournal-d-18-00004.1 Get It